You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced (inoperable) or Metastatic Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial (utidelone)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • (no location specified)
May 30, 2022

A Real-world Study of Inetetamab for First-line Treatment of MBC

Not yet recruiting
  • Breast Cancer
  • Real-world Study
  • (no location specified)
Aug 6, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Triple Negative Breast Cancer Trial in Australia, United States (biological, device, drug)

Recruiting
  • Triple Negative Breast Cancer
  • tavokinogene telseplasmid
  • +3 more
  • Tucson, Arizona
  • +12 more
Apr 18, 2022

Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

Recruiting
  • Neoplasm Malignant
  • +4 more
  • Atlanta, Georgia
  • +4 more
Apr 19, 2022

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Trial in Worldwide (Giredestrant, Abemaciclib,

Recruiting
  • Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
  • Duarte, California
  • +27 more
Jan 31, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC) Trial in Dijon Cedex, Saint-Herblain Cédex, Hospitalet

Terminated
  • Inoperable Locally Advanced Breast Cancer
  • Metastatic Breast Cancer (MBC)
  • Dijon Cedex, France
  • +2 more
Dec 6, 2020

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

Recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Los Angeles, California
  • +76 more
Nov 25, 2022

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

Perjeta in First-Line Treatment in Her2-Positive Advanced Breast

Completed
  • Breast Cancer
    • Frankfurt, Germany
      AGAPLESION Markus-Krankenhaus
    Dec 10, 2020

    Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 2, 2023

    Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets 400mg, SPH4336 Tablets Placebo)

    Not yet recruiting
    • Locally Advanced or Metastatic Breast Cancer
    • SPH4336 Tablets 400mg
    • SPH4336 Tablets Placebo
    • Guangzhou, Guangdong, China
      Affiliated Cancer Hospital, Sun Yat-sen University
    Feb 24, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Feb 27, 2023

    Triple Negative Breast Cancer (TNBC) Trial (Pembrolizumab, Nab-paclitaxel, Paclitaxel)

    Active, not recruiting
    Has Results
    • Triple Negative Breast Cancer (TNBC)
    • Pembrolizumab
    • +5 more
    • (no location specified)
    Jul 15, 2022

    Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

    Not yet recruiting
    • Breast Cancer
    • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
    • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
    • (no location specified)
    Feb 22, 2023

    Intrahepatic Cholangiocarcinoma Trial (derazantinib)

    Available
    • Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Jan 13, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023